115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) ≥3y on nivolumab (NIVO) ± ipilimumab (IPI) or IPI in checkmate 067
    Meeting Abstract

    Hodi, F. S.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic landscape of EGFR -mutant lung cancers (LCs) with squamous and adenosquamous differentiation
    Meeting Abstract

    Elkrief, A.; Falcon, C. J.; Richards, A. L.; Dymun, A.; Paik, P. K.; Aly, R. G.; Rekhtman, N.; Rudin, C. M.; Quintanal-Villalonga, A.; Yu, H. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Detection of MET amplification (METamp) in patients with EGFR mutant (m) NSCLC after first-line (1L) osimertinib
    Meeting Abstract

    Yu, H. A.; Kerr, K.; Rolfo, C. D.; Fang, J.; Finocchiaro, G.; Wong, K. H.; Veillon, R.; Kato, T.; Yang, J. C. H.; Nadal, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Characterization of diverse targetable alterations in ERBB2 and ERBB3 in 93,465 non-small cell lung cancers (NSCLC)
    Meeting Abstract

    Liu, D.; Keller, R. B.; Heilmann, A. M.; Allen, J.; Oxnard, G. R.; Bazhenova, L.; Schrock, A. B.; Li, B. T.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer
    Meeting Abstract

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Luo, J.; Alessi, J. V. M.; Pecci, F.; Lamberti, G.; Hong, Lingzhi; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Changes in PD-L1 and tumor mutational burden between paired samples and relationship to immune checkpoint inhibitor outcomes in non-small cell lung cancer
    Meeting Abstract

    Di Federico, A.; Alden, S. L.; Smithy, J. W.; Ricciuti, B.; Alessi, J. V. M.; Wang, X.; Pecci, F.; Gandhi, M. M.; Lamberti, G.; Spurr, L. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Meeting Abstract

    Arbour, K. C.; Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of tepotinib in patients with MET exon 14 skipping NSCLC from the VISION study
    Meeting Abstract

    Paik, P. K.; Garassino, M. C.; Le, X.; Thomas, M.; Sakai, H.; Veillon, R.; Smit, E. F.; Mazieres, J.; Cortot, A. B.; Raskin, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Emerging phase 1 data of BLU-451 in advanced NSCLC with EGFR exon 20 insertions
    Meeting Abstract

    Nguyen, D.; Shum, E.; Baik, C. S.; Janne, P. A.; Patel, J. D.; Schenk, E. L.; Shibata, Y.; Yu, H. A.; Albayya, F.; Pearson, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save